Toho Holdings Co., Ltd. Stocks

¥ 4445Last Updated 27.04.2026

Issuer Rating

7/7
Performance

Strong

Risk

Low

Recommendation

Buy

Market Cap

¥ 1.77B

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
¥ 4445
Key Takeaways

Risk factor

Negligible price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Toho Holdings Co., Ltd. engages in the wholesale distribution of pharmaceutical products in Japan. It sells prescription pharmaceuticals, reagents, medical devices and materials, OTC drugs, health foods, preventive care, clinical care, community healthcare linkage, and home medical and nursing care, as well as provides support services, including the development and sale of customer support systems, assistance in the start-up of medical institutions and pharmacies, management consulting services, medical support, and personnel recruitment. The company also engages in dispensing pharmacy business; manufacture and sale of generic drugs; and site management organization business that assists various medical institutions with clinical trials under contract, as well as sells software to medical institutions. In addition, it provides various customer support systems, including ENIF, an information terminal for pharmaceutical ordering; ENI-Pharmacy, a support system for the separation of dispensing and prescribing functions; LXMATE HeLios a medical care appointment system; KAITOS, an online medical consultation and medication guidance system; ENIFwin, an inventory control system for large hospitals; ENIFvoice SP/ ENIFvoice SP + A/ ENIFvoice Core, a supporting system for electronic medication history recording with voice recognition; and ENIF Nurse, an operation support terminal for home-visit nurses; and logistics systems. The company was incorporated in 1948 and is headquartered in Tokyo, Japan.

Company Valuation

Greatly undervalued
7/7

From both historical and forecast perspectives, the stock is considerably underpriced compared to similar stocks. Specifically, the stock is fairly valued on P/E, underva

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Neutral
4/7

The average target price of 8129.T is 4880 and suggests 10% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendatio

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks